Dichotomous and stable gamma delta T-cell number and function in healthy individuals
Adult
Cytotoxicity, Immunologic
Male
0301 basic medicine
Skin Neoplasms
Lymphocyte Activation
Immunophenotyping
03 medical and health sciences
Cell Movement
Cell Line, Tumor
Humans
Lymphocyte Count
Intraepithelial Lymphocytes
Melanoma
RC254-282
Cell Proliferation
Clinical/Translational Cancer Immunotherapy
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Middle Aged
Coculture Techniques
Healthy Volunteers
3. Good health
Phenotype
Female
Immunologic Memory
Biomarkers
DOI:
10.1136/jitc-2020-002274
Publication Date:
2021-05-19T17:36:03Z
AUTHORS (21)
ABSTRACT
Background Gamma-delta (γδ) T lymphocytes are primed to potently respond pathogens and transformed cells by recognizing a broad range of antigens. However, adoptive immunotherapy with γδT has exhibited mixed treatment responses. Better understanding cell biology stratifying healthy donors for allogeneic therapy is clinically needed fully realize the therapeutic potential cells. Methods We examine 98 blood samples from measure their expansion capacity after zoledronate stimulation, test migration cytotoxic effector function expanded in 2D culture, 3D tumor spheroid patient-derived melanoma organoid assays. Results find that independent methods, gender, age HLA type. Basal levels Peripheral mononuclear (PBMC) correlate well expansion, vitro. Circulating lower expression PD-1, CTLA-4, Eomes, T-bet CD69, or higher IFN-γ production expand better. central memory phenotypes significantly more abundant good expanders. A cut-off level 0.82% PBMC stratifies versus poor sensitivity 97.78%, specificity 90.48% area under curve 0.968 individual. Donors Vδ2 Index Score have greater anti-tumor functions including migratory cytotoxicity. Conclusions Our results demonstrate interindividual circulating donors. Examination may be used select participate γδT-based immunotherapies.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (42)
CITATIONS (17)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....